Recipharm to complete full commercial manufacture of Plenadren for adrenal …pharmabiz.comRecipharm, the international contract pharmaceutical development and manufacturing organization, has been contracted by ViroPharma to complete commercial scale-u…
Fusion IP portfolio co Diurnal raises £335000 for developing lead product …Proactive Investors USA & CanadaBased in Cardiff, Diurnal is developing a novel approach to drug delivery that will help patients suffering from reduced levels of the key hor…
AEROCRINE AB : BlueCross BlueShield of Florida Continues Trend, Retires …4-tradersFeNO testing can also help physicians identify patients who will be responsive to treatment with anti-inflammatory medications such as inhaled corticosteroids (ICS), an…
Inhaled Beclomethasone Bests Fluticasone (Advair) When HIV PIs Being UsedAIDSmeds.com HIV/AIDS Treatment NewsAs explained by US Food and Drug Administration (FDA) and National Institutes of Health (NIH) investigators who reported the data, people livin…
Long-Term Outcomes Similar for ECDs, SCDsRenal and Urology NewsIn July 1997, the transplant team at the McGill University Health Centre changed the immunosuppressive regimen for kidney recipients from cyclosporine to tacrolimus and from azathioprine to…
FUSION IP PLC : Diurnal, raises £335k to complete Chronocort Phase I trial and …4-tradersBased in Cardiff, Diurnal is developing a novel approach to drug delivery that will help patients suffering from reduced levels of the key hormone cortisol (hyd…
Stent Wars: Judge doubles down on $20M jury award to Boston Scientific in …Mass DeviceIn June 2011, a federal appeals court upheld Robinson's ruling in another case that J&J's patent covering the sirolimus (also called rapamycin) used in …
T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary …7thSpace Interactive (press release)The clinical benefits of corticosteroids in COPD patients are limited. Our hypothesis is that lymphocytes play a role in this corticos…
Recipharm Contracted for Commercial Manufacture of ViroPharma's PlenadrenGenetic Engineering NewsViroPharma contracted Recipharm to carry out full commercial-scale manufacture of Plenadren®, a modified release hydrocortisone drug approved in Europ…
Renal Cancer Therapeutics: Now What?Cancer NetworkBy Walter M. Stadler, MD, FACP 1 | March 13, 2012 The development of vascular endothelial growth factor (VEGF) pathway inhibitors and mammalian target of rapamycin (mTOR) inhibitors for the treatment of…